Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation by Okarmus, J, Bogetofte, H, Schmidt, SI, Ryding, M, García-López, S, Ryan, BJ, Martínez-Serrano, A, Hyttel, P, Meyer, M

Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism by Okarmus, J, Havelund, JF, Ryding, M, Schmidt, SI, Bogetofte, H, Heon-Roberts, R, Wade-Martins, R, Cowley, SA, Ryan, BJ, Færgeman, NJ, Hyttel, P, Meyer, M

Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation by Bogetofte, H, Jensen, P, Okarmus, J, Schmidt, SI, Agger, M, Ryding, M, Nørregaard, P, Fenger, C, Zeng, X, Graakjær, J, Ryan, BJ, Wade-Martins, R, Larsen, MR, Meyer, M

PARK2 mutation causes metabolic disturbances and impaired survival of human iPSC-derived neurons by Bogetofte, H, Jensen, P, Ryding, M, Schmidt, SI, Okarmus, J, Ritter, L, Worm, CS, Hohnholt, MC, Azevedo, C, Roybon, L, Bak, LK, Waagepetersen, H, Ryan, BJ, Wade-Martins, R, Larsen, MR, Meyer, M

The Validity of Intracerebral Hemorrhage Diagnoses in the Danish Patient Registry and the Danish Stroke Registry by Hald SM, Kring Sloth C, Agger M, Schelde-Olesen MT, Højholt M, Hasle M, Bogetofte H, Olesrud I, Binzer S, Madsen C, Krone W, García Rodríguez LA, Al-Shahi Salman R, Hallas J, Gaist D

Get full text

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons by Fernandes, H, Hartfield, E, Christian, H, Emmanoulidou, E, Zheng, Y, Booth, H, Bogetofte, H, Lang, C, Ryan, B, Sardi, S, Badger, J, Vowles, J, Evetts, S, Tofaris, G, Vekrellis, K, Talbot, K, Hu, M, James, W, Cowley, S, Wade-Martins, R